<p>富蘭克林資源公司在第二季度購買了 Omada Health, Inc.（NASDAQ:OMDA - 免費報告）的新股份，根據該公司最近向證券交易委員會提交的 13F 文件。該基金購買了 147,251 股公司的股票，價值約為 2,695,000 美元。富蘭克林資源公司在最近一個季度末持有 Omada Health 約 0.57% 的股份。</p>
<p>其他幾家機構投資者也最近調整了對該公司的持股。Geode Capital Management LLC 在第二季度購買了價值約 637,000 美元的 Omada Health 新頭寸。德克薩斯州教師退休系統在第二季度購買了價值約 640,000 美元的 Omada Health 新頭寸。Emerald Mutual Fund Advisers Trust 在第二季度購買了價值約 2,950,000 美元的 Omada Health 新股份。Jennison Associates LLC 在第二季度購買了價值約 4,580,000 美元的 Omada Health 新股份。最後，Emerald Advisers LLC 在第二季度購買了價值約 5,089,000 美元的 Omada Health 新股份。</p>
<h2>華爾街分析師預測增長</h2>
<p>幾家研究公司對 OMDA 發表了評論。Needham &amp; Company LLC 將 Omada Health 的目標價格從 26.00 美元上調至 28.00 美元，並在 11 月 7 日的報告中給予該股票 “買入” 評級。巴克萊將 Omada Health 的目標價格從 28.00 美元上調至 29.00 美元，並在 11 月 7 日的研究報告中給予該股票 “增持” 評級。Evercore ISI 將 Omada Health 的目標價格從 27.00 美元上調至 28.00 美元，並在 11 月 7 日的研究報告中給予該公司 “跑贏大盤” 評級。Canaccord Genuity Group 將 Omada Health 的目標價格從 27.00 美元上調至 28.00 美元，並在 8 月 8 日的研究報告中給予該股票 “買入” 評級。最後，Baird R W 在 9 月 5 日的報告中將 Omada Health 的股票評級上調至 “持有”。八位分析師對該股票給予了買入評級，兩位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 “適度買入”，平均目標價格為 26.33 美元。</p>
<p><strong>查看我們對 Omada Health 的最新股票分析</strong></p>
<h2>Omada Health 股價下跌 12.6%</h2>
<p>OMDA 週四開盤價為 16.13 美元。該公司的 50 日移動平均線為 22.24 美元。Omada Health, Inc.的 52 周低點為 14.14 美元，52 周高點為 28.40 美元。</p>
<h2>Omada Health 簡介</h2>
<p>（免費報告）</p>
<p>Omada 的使命是改變趨勢。我們的希望是，有一天，明天的流行病學家會注意到疾病曲線的變化，想知道發生了什麼，並得出部分影響來自 Omada 的結論。作為這一使命的一部分，我們努力激勵和幫助人們以自己的方式實現持久的健康改變。</p>
<h2>精選文章</h2>
<ul>
<li>五隻我們更看好的股票超過 Omada Health</li>
<li>股票中的死亡交叉是什麼？</li>
<li>3 只有望受益於谷歌 AI 突破的股票</li>
<li>上海證券交易所綜合指數是什麼？</li>
<li>超越 NVIDIA：5 只將在 2026 年主導的半導體股票</li>
<li>股息之王寶潔在財報後疲軟時值得買入</li>
<li>3 只你會希望在 2026 年前買入的股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T01EQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T01EQQ"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Omada Health 嗎？</h2>
<p>在你考慮 Omada Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出頂級分析師正在悄悄向客户推薦的五隻股票，建議現在買入，以便在更廣泛的市場注意到之前……而 Omada Health 並不在名單上。</p>
<p>雖然 Omada Health 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得買入。</p>
<p>在這裏查看這五隻股票</p>

OMDA

富蘭克林資源

<p>富蘭克林資源公司在第二季度收購了 147,251 股 Omada Health 公司的股份，價值為 2,695,000 美元。分析師對 Omada Health 給予了 “適度買入” 的評級，目標價格範圍在 26 美元到 29 美元之間。儘管如此，該股票目前交易下跌 12.6%，報 16.13 美元。在同一時期，其他幾家機構投資者也購買了 Omada Health 的股份</p>

<p>Franklin Resources Inc. bought a new stake in shares of Omada Health, Inc. (NASDAQ:OMDA - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 147,251 shares of the company's stock, valued at approximately $2,695,000. Franklin Resources Inc. owned approximately 0.57% of Omada Health at the end of the most recent quarter.</p>
<div class="lb-trans"><p>富蘭克林資源公司在第二季度購買了 Omada Health, Inc.（NASDAQ:OMDA - 免費報告）的新股份，根據該公司最近向證券交易委員會提交的 13F 文件。該基金購買了 147,251 股公司的股票，價值約為 2,695,000 美元。富蘭克林資源公司在最近一個季度末持有 Omada Health 約 0.57% 的股份。</p>
</div><p>Several other institutional investors also recently modified their holdings of the business. Geode Capital Management LLC purchased a new position in Omada Health during the 2nd quarter valued at about $637,000. Teacher Retirement System of Texas purchased a new position in shares of Omada Health during the second quarter valued at approximately $640,000. Emerald Mutual Fund Advisers Trust bought a new stake in shares of Omada Health in the 2nd quarter worth approximately $2,950,000. Jennison Associates LLC purchased a new stake in shares of Omada Health in the 2nd quarter worth approximately $4,580,000. Finally, Emerald Advisers LLC purchased a new stake in shares of Omada Health in the 2nd quarter worth approximately $5,089,000.</p>
<div class="lb-trans"><p>其他幾家機構投資者也最近調整了對該公司的持股。Geode Capital Management LLC 在第二季度購買了價值約 637,000 美元的 Omada Health 新頭寸。德克薩斯州教師退休系統在第二季度購買了價值約 640,000 美元的 Omada Health 新頭寸。Emerald Mutual Fund Advisers Trust 在第二季度購買了價值約 2,950,000 美元的 Omada Health 新股份。Jennison Associates LLC 在第二季度購買了價值約 4,580,000 美元的 Omada Health 新股份。最後，Emerald Advisers LLC 在第二季度購買了價值約 5,089,000 美元的 Omada Health 新股份。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><p>Several research firms have commented on OMDA. Needham &amp; Company LLC boosted their target price on Omada Health from $26.00 to $28.00 and gave the stock a &#34;buy&#34; rating in a report on Friday, November 7th. Barclays upped their price target on shares of Omada Health from $28.00 to $29.00 and gave the stock an &#34;overweight&#34; rating in a research note on Friday, November 7th. Evercore ISI raised their price objective on shares of Omada Health from $27.00 to $28.00 and gave the company an &#34;outperform&#34; rating in a research note on Friday, November 7th. Canaccord Genuity Group upped their target price on shares of Omada Health from $27.00 to $28.00 and gave the stock a &#34;buy&#34; rating in a research note on Friday, August 8th. Finally, Baird R W upgraded shares of Omada Health to a &#34;hold&#34; rating in a report on Friday, September 5th. Eight analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $26.33.</p>
<div class="lb-trans"><p>幾家研究公司對 OMDA 發表了評論。Needham &amp; Company LLC 將 Omada Health 的目標價格從 26.00 美元上調至 28.00 美元，並在 11 月 7 日的報告中給予該股票 “買入” 評級。巴克萊將 Omada Health 的目標價格從 28.00 美元上調至 29.00 美元，並在 11 月 7 日的研究報告中給予該股票 “增持” 評級。Evercore ISI 將 Omada Health 的目標價格從 27.00 美元上調至 28.00 美元，並在 11 月 7 日的研究報告中給予該公司 “跑贏大盤” 評級。Canaccord Genuity Group 將 Omada Health 的目標價格從 27.00 美元上調至 28.00 美元，並在 8 月 8 日的研究報告中給予該股票 “買入” 評級。最後，Baird R W 在 9 月 5 日的報告中將 Omada Health 的股票評級上調至 “持有”。八位分析師對該股票給予了買入評級，兩位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 “適度買入”，平均目標價格為 26.33 美元。</p>
</div><p><strong>Check Out Our Latest Stock Analysis on Omada Health</strong></p>
<div class="lb-trans"><p><strong>查看我們對 Omada Health 的最新股票分析</strong></p>
</div><h2>Omada Health Trading Down 12.6%</h2>
<div class="lb-trans"><h2>Omada Health 股價下跌 12.6%</h2>
</div><p>OMDA opened at $16.13 on Thursday. The company's 50-day moving average is $22.24. Omada Health, Inc. has a 52-week low of $14.14 and a 52-week high of $28.40.</p>
<div class="lb-trans"><p>OMDA 週四開盤價為 16.13 美元。該公司的 50 日移動平均線為 22.24 美元。Omada Health, Inc.的 52 周低點為 14.14 美元，52 周高點為 28.40 美元。</p>
</div><h2>Omada Health Profile</h2>
<div class="lb-trans"><h2>Omada Health 簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Omada's mission is to bend the curve. Our hope is that, one day, tomorrow's epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.</p>
<div class="lb-trans"><p>Omada 的使命是改變趨勢。我們的希望是，有一天，明天的流行病學家會注意到疾病曲線的變化，想知道發生了什麼，並得出部分影響來自 Omada 的結論。作為這一使命的一部分，我們努力激勵和幫助人們以自己的方式實現持久的健康改變。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than Omada Health</li>
<li>What is a Death Cross in Stocks?</li>
<li>3 Stocks Poised to Benefit From Google’s AI Breakthough</li>
<li>What is the Shanghai Stock Exchange Composite Index?</li>
<li>Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026</li>
<li>Dividend King Proctor &amp; Gamble Is A Buy On Post-Earnings Weakness</li>
<li>3 Stocks You’ll Wish You Bought Before 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票超過 Omada Health</li>
<li>股票中的死亡交叉是什麼？</li>
<li>3 只有望受益於谷歌 AI 突破的股票</li>
<li>上海證券交易所綜合指數是什麼？</li>
<li>超越 NVIDIA：5 只將在 2026 年主導的半導體股票</li>
<li>股息之王寶潔在財報後疲軟時值得買入</li>
<li>3 只你會希望在 2026 年前買入的股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T01EQQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=OMDA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Omada Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Omada Health 嗎？</h2>
</div><p>Before you consider Omada Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Omada Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omada Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出頂級分析師正在悄悄向客户推薦的五隻股票，建議現在買入，以便在更廣泛的市場注意到之前……而 Omada Health 並不在名單上。</p>
</div><p>While Omada Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Omada Health 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得買入。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

富蘭克林資源公司對 Omada Health 公司進行了新的投資 $OMDA